Aspira Pathlab & Diagnostics
Aspira Pathlab & Diagnostics Share Price Chart
Aspira Pathlab & Diagnostics last traded at ₹109.25 (2026-10-13). Over the past month the stock moved +15.5%, three months the stock moved -12.1%, year the stock moved +85.2%. Its closing range over 52 weeks is ₹54.75 – ₹143.34, with the latest close 23.8% below the high.
Closing prices up to 2026-10-13.
About Aspira Pathlab & Diagnostics
Incorporated in 1973, Aspira Pathlab & Diagnostics Ltd is in the business of pathology and related healthcare services[1]
Business Overview:[1][2][3] Aspira Pathlab & Diagnostics Ltd (APDL) provides pathology and radiology investigation services through diagnostic centers in Mumbai. Serving B2B and B2C markets, the company offers diagnostic solutions to individual patients, hospitals, healthcare providers, and businesses.
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Aspira Pathlab & Diagnostics reported sales of ₹6.17 crore (+17.5%) and net profit of ₹-0.04 crore (-108.5%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 6.17 | 0.34 | 5.51 | -0.04 | -0.04 |
| Mar 2026 | 6.52 | -0.33 | -5.06 | -0.69 | -0.67 |
| Dec 2025 | 5.12 | -1.21 | -23.63 | -1.56 | -1.52 |
| Sep 2025 | 8.09 | 2.19 | 27.07 | 1.84 | 1.79 |
| Jun 2025 | 5.25 | 0.81 | 15.43 | 0.47 | 0.46 |
| Mar 2025 | 5.78 | 1.05 | 18.17 | 0.72 | 0.70 |
| Dec 2024 | 5.41 | 0.76 | 14.05 | 0.38 | 0.37 |
| Sep 2024 | 6.18 | 1.35 | 21.84 | 0.99 | 0.96 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +86.1% | +56.4% | +51.3% | +13.1% | +30.9% | -5.4% | +12.8% | +17.5% |
| Operating profit growth | – | – | – | +131.4% | +62.2% | -259.2% | -131.4% | -58.0% |
| Net profit growth | – | – | – | – | +85.9% | -510.5% | -195.8% | -108.5% |
| EPS growth | – | – | – | – | +86.5% | -510.8% | -195.7% | -108.7% |
| OPM % | 21.8% | 14.1% | 18.2% | 15.4% | 27.1% | -23.6% | -5.1% | 5.5% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Aspira Pathlab & Diagnostics reported sales of ₹24.98 crore (+13.5%) and net profit of ₹0.05 crore (-97.6%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 24.98 | 1.46 | 5.84 | 0.05 | 0.05 |
| Mar 2025 | 22.00 | 3.53 | 16.05 | 2.07 | 2.01 |
| Mar 2024 | 13.20 | -1.18 | -8.94 | -2.67 | -2.59 |
| Mar 2023 | 14.46 | 1.60 | 11.07 | -0.09 | -0.09 |
| Mar 2022 | 19.54 | 6.38 | 32.65 | 4.46 | 4.33 |
| Mar 2021 | 15.21 | 3.52 | 23.14 | 1.38 | 1.34 |
| Mar 2020 | 8.42 | -1.83 | -21.73 | -4.24 | -4.56 |
| Mar 2019 | 7.64 | -3.24 | -42.41 | -5.18 | -6.32 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +75.2% | +10.2% | +80.6% | +28.5% | -26.0% | -8.7% | +66.7% | +13.5% |
| Operating profit growth | – | – | – | +81.3% | -74.9% | -173.7% | – | -58.6% |
| Net profit growth | – | – | – | +223.2% | -102.0% | – | – | -97.6% |
| EPS growth | – | – | – | +223.1% | -102.1% | – | – | -97.5% |
| OPM % | -42.4% | -21.7% | 23.1% | 32.7% | 11.1% | -8.9% | 16.1% | 5.8% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Aspira Pathlab & Diagnostics .
Get Free AI Stock Analysis FREE →Latest News
-
Aspira Pathlab & Diagnostics reports standalone net loss of Rs 0.04 crore in the June 2026 quarter - Business Standard
Frequently Asked Questions
What is the share price of Aspira Pathlab & Diagnostics today?
Aspira Pathlab & Diagnostics shares were last quoted at ₹109.25 (-5.0% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Aspira Pathlab & Diagnostics ?
Aspira Pathlab & Diagnostics has a price-to-earnings (P/E) ratio of 54.41 and a price-to-book (P/B) ratio of 18.03. The industry P/E is 102.95.
What is the 52-week high and low of Aspira Pathlab & Diagnostics ?
The 52-week high of Aspira Pathlab & Diagnostics is ₹135.88 and the 52-week low is ₹49.00.
What is the market cap of Aspira Pathlab & Diagnostics ?
The market capitalisation of Aspira Pathlab & Diagnostics is about ₹130.49 crore.
How did Aspira Pathlab & Diagnostics perform in its latest quarterly results?
In the latest quarter (Jun 2026), Aspira Pathlab & Diagnostics reported sales of ₹6.17 crore (+17.5%) and net profit of ₹-0.04 crore (-108.5%), compared with the same quarter last year.
Is Aspira Pathlab & Diagnostics a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Aspira Pathlab & Diagnostics has a 3-year ROE of -2.00%, 3-year profit growth of 37.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Aspira Pathlab & Diagnostics ?
Promoters hold about 46.58% of Aspira Pathlab & Diagnostics .
Which sector does Aspira Pathlab & Diagnostics belong to?
Aspira Pathlab & Diagnostics belongs to the Hospital & Healthcare Services sector.
Other Hospital & Healthcare Services stocks
- Apollo Hospitals Enterprises
- Max Healthcare Institute
- Manipal Health Enterprises
- Aster DM Quality Care
- Fortis Healthcare
- Global Health
- Narayana Hrudayalaya
- Krishna Institute of Medical Sciences
All Hospital & Healthcare Services stocks · Browse all stocks A–Z